Heparan Sulfate, Including That in Bruch’s Membrane, Inhibits the Complement Alternative Pathway: Implications for Age-Related Macular Degeneration

MLA

Jindong Ding, et al. “Heparan Sulfate, Including That in Bruch’s Membrane, Inhibits the Complement Alternative Pathway: Implications for Age-Related Macular Degeneration.” The Journal of Immunology, vol. 185, Nov. 2010, pp. 5486–94. EBSCOhost, https://doi.org/10.4049/jimmunol.0903596.

APA

Jindong Ding, Michael M. Frank, L. Yu, Catherine Bowes Rickman, Gregory S. Hageman, Michael A. Hauser, Vadim Y. Arshavsky, Haixiang Jiang, Pallavi Kumar, & Una Kelly. (2010). Heparan Sulfate, Including That in Bruch’s Membrane, Inhibits the Complement Alternative Pathway: Implications for Age-Related Macular Degeneration. The Journal of Immunology, 185, 5486–5494. https://doi.org/10.4049/jimmunol.0903596

Chicago

Jindong Ding, Michael M. Frank, L. Yu, Catherine Bowes Rickman, Gregory S. Hageman, Michael A. Hauser, Vadim Y. Arshavsky, Haixiang Jiang, Pallavi Kumar, and Una Kelly. 2010. “Heparan Sulfate, Including That in Bruch’s Membrane, Inhibits the Complement Alternative Pathway: Implications for Age-Related Macular Degeneration.” The Journal of Immunology 185 (November): 5486–94. doi:10.4049/jimmunol.0903596.